Clinical Trial Update: Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the effects of an anticholinergic or a long-acting beta-2 agonist on FeNO and pulmonary function in individuals with sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Spinal Cord Injury | Phase 1 | Status: UNKNOWN